Market Tracker

11/26 6:05pm ET

Cleveland Biolabs Inc (NASDAQ:CBLI)

0.3758
Data as of Nov 26
 -0.0042 / -1.11%
Today’s Change
0.33
Today|||52-Week Range
1.40
-67.88%
Year-to-Date
No recent news for Cleveland Biolabs Inc.

Today’s Trading

Previous close0.38
Today’s open0.38
Day’s range0.37 - 0.40
Volume105,767
Average volume (3 months)250,354
Market cap$21.7M
Dividend yield--
Data as of 3:58pm ET, 11/26/2014

Growth & Valuation

Earnings growth (last year)+22.45%
Earnings growth (this year)+63.94%
Earnings growth (next 5 years)--
Revenue growth (last year)+137.71%
P/E ratioNM
Price/Sales6.20
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NYMXNymox Pharmaceutical...-0.01-1.64%
--RepliCel Life Scienc...-0.07-17.88%
PRPHProPhase Labs Inc+0.02+1.43%
REPHRecro Pharma Inc0.000.00%
Data as of 3:59pm ET, 11/26/2014

Financials

Next reporting dateMarch 10, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$8.5M
Annual profit (last year)-$17.3M
Net profit margin-203.38%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Yakov Kogan
Secretary, VP-Compliance &
Operations
Leah Brownlee
Corporate headquarters
Buffalo, New York

Forecasts